deslorelin

Animal productexperimental

Deslorelin, sold under the brand name Suprelorin among others, is an injectable gonadotropin releasing hormone superagonist which is used in veterinary medicine for various indications. — Wikipedia

Clinical trial activity

4 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 1983 (NCT00001190)

Timeline

1980s

  1. Jan 1, 1983

    Earliest Phase 2 Sponsor(trial)

1990s

  1. Jan 1, 1996

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1
Mol. weight
1282.47 g/mol
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 6-trp-10-n-et-glynh2-lhrh
  • deslorelin
  • deslorelin
  • deslorelin
  • deslorelin
  • deslorelin acetate
  • d-trp(6)-n-et-d-glynh2(10)-lhrh
  • d-trp lhrh-pea
  • d-trp lhrh-pea
  • gnrh, trp(6)-n-et-glynh2(10)-
  • lhrh, trp(6)-n-et-glynh2(10)-
  • lhrh, tryptophyl(6)-n-ethylglycinamide(10)-
  • ovuplant
  • somagard
  • somagard [as acetate]

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00080756Phase 2Feb 1, 2004City of Hope National Medical Center, National Cancer Institute (NCI)
NCT00001521Phase 1Feb 2, 1996National Institutes of Health (NIH)
NCT00001202Phase 2Jan 1, 1985National Institutes of Health (NIH)
NCT00001190Phase 2Nov 1, 1983National Institutes of Health (NIH)
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institutes of Health (NIH)Government3321983
City of Hope National Medical CenterAcademic/Hospital1112004
National Cancer Institute (NCI)Government1012004
3 organizations
Page 1 / 1